ALKERMES
Alkermes, Inc. is an integrated biotechnology company. The Company is engaged in the business of developing, manufacturing and commercializing medicines for the treatment of prevalent, chronic diseases. Alkermes, Inc. develops, manufactures and commercializes VIVITROL for alcohol dependence and manufacture RISPERDAL CONSTA for schizophrenia and bipolar I disorder. Its pipeline includes extended-release injectable and oral products for the treatment of prevalent, chronic diseases, such as central... nervous system (CNS), disorders, reward disorders, addiction, diabetes and autoimmune disorders. The Company has a research facility in Massachusetts and a commercial manufacturing facility in Ohio. RISPERDAL CONSTA is used for the treatment of schizophrenia and for the treatment of bipolar I disorder. VIVITROL is an extended-release MEDISORB formulation of naltrexone, as a once-monthly injectable medication for the treatment of alcohol dependence.
ALKERMES
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1987-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.alkermes.com
Total Employee:
1001+
Status:
Active
Contact:
+353 1 772 8000
Total Funding:
250 M USD
Technology used in webpage:
Domain Not Resolving Apple Mobile Web Clips Icon Amazon Mobile Non Scaleable Content Nginx Cloudflare Hosting Cloudflare CDN Google Google Cloud DNSSEC
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Evox Therapeutics
Evox Therapeutics is a biotechnology company that harnesses and engineer the natural trafficking capabilities of extracellular vesicles.
MediGene
MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.
Noema Pharma
Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Current Advisors List
Board_member
2003-04-01
Board_member
Board_member
Board_member
2008-10-01
Board_member
Board_member
1999-01-01
Board_member
2011-01-01
Board_member
2013-05-01
Current Employees Featured
Craig Hopkinson CMO and Head of Clinical Development and Medical Affairs @ Alkermes
CMO and Head of Clinical Development and Medical Affairs
2017-05-01
David Daglio Non Executive Director @ Alkermes
Non Executive Director
2020-12-01
Kimberly Curtin Associate Director, Thought Leader Engagement Marketing @ Alkermes
Associate Director, Thought Leader Engagement Marketing
2022-07-01
Richard Pops CEO @ Alkermes
CEO
2009-01-01
Katie Joyce Vice President of Corporate Affairs @ Alkermes
Vice President of Corporate Affairs
2021-04-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-11-18 | Rodin Therapeutics | Rodin Therapeutics acquired by Alkermes | N/A |
| 1999-07-13 | Advanced Inhalation Research | Advanced Inhalation Research acquired by Alkermes | N/A |
| 1993-01-01 | Enzytech | Enzytech acquired by Alkermes | N/A |
Investors List
Primecap Management
Primecap Management investment in Post-IPO Equity - Alkermes
Invesco
Invesco investment in Post-IPO Equity - Alkermes
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2023-11-15 | Mural Oncology | Alkermes investment in Corporate Round - Mural Oncology | 275 M USD |
| 2023-08-31 | She Recovers Foundation | Alkermes investment in Grant - She Recovers Foundation | N/A |
| 2023-08-31 | NAMI Mobile | Alkermes investment in Grant - NAMI Mobile | N/A |
| 2023-08-31 | American Psychiatric Association | Alkermes investment in Grant - American Psychiatric Association | N/A |
| 2023-08-31 | CSG Justice Center | Alkermes investment in Grant - CSG Justice Center | N/A |
| 2023-08-31 | The Recovery Community Network | Alkermes investment in Grant - The Recovery Community Network | N/A |
| 2023-08-31 | Caregiver Action Network | Alkermes investment in Grant - Caregiver Action Network | N/A |
| 2023-08-31 | Foundation for Women's Cancer | Alkermes investment in Grant - Foundation for Women's Cancer | N/A |
| 2023-08-31 | Ohio Chamber of Commerce Research Foundation | Alkermes investment in Grant - Ohio Chamber of Commerce Research Foundation | N/A |
| 2023-08-31 | Cancer Legal Care | Alkermes investment in Grant - Cancer Legal Care | N/A |
Newest Events participated
Participated in The Next Era in Innovation
on 2017-04-13 as sponsor
Official Site Inspections
http://www.alkermes.com Semrush global rank: 1.37 M Semrush visits lastest month: 18.93 K
- Host name: 72.32.33.202
- IP address: 72.32.33.202
- Location: San Antonio United States
- Latitude: 29.4963
- Longitude: -98.4004
- Metro Code: 641
- Timezone: America/Chicago
- Postal: 78218
More informations about "Alkermes"
About Alkermes | Alkermes
Alkermes is committed to diversity, inclusion and belonging (DIB) in various aspects of our business. We strive to foster an environment of equality and compassion, where all voices are …See details»
Alkermes plc - Wikipedia
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies (EDT), the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturi…See details»
Alkermes - Crunchbase Company Profile & Funding
Alkermes, Inc. is an integrated biotechnology company. The Company is engaged in the business of developing, manufacturing and commercializing medicines for the treatment of prevalent, …See details»
Org Chart Alkermes - The Official Board
The organizational chart of Alkermes displays its 54 main executives including Richard Pops, Iain Brown and Blair Jackson. Toggle navigation The Official Board. Search. Search. Search by segment. Sign In. Business E-mail* …See details»
Disease Areas | Alkermes
Applying experience in neuroscience to address significant unmet needs in psychiatric and neurological disorders. We aim to make a meaningful difference for people living with serious …See details»
Alkermes Company Profile | Management and Employees List
Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland. ...Read More. Popular Searches. Alkermes Inc. Alkermes. Alkermes PLC. Alkermes Controlled Therapeutics Inc. …See details»
Alkermes - Funding, Financials, Valuation & Investors - Crunchbase
Alkermes is registered under the ticker NASDAQ:ALKS . Alkermes is funded by 2 investors. Primecap Management and Invesco are the most recent investors. Alkermes has made 15 …See details»
Alkermes - The Org
Alkermes plc is a pharmaceutical manufacturing and biopharmaceutical company developing innovative medicines to help patients with serious chronic conditions.See details»
Alkermes - PharmaSource
Alkermes is a global biopharmaceutical company committed to developing innovative medicines for complex diseases. Based in Dublin, Ireland, Alkermes focuses on creating treatments for …See details»
Alkermes Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 Alkermes is a leader in innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global …See details»
Alkermes to Report Fourth Quarter and Year-End Financial Results …
DUBLIN, Feb. 5, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. GMT) on Wednesday, Feb. 12, 2025 to …See details»
Alkermes - Overview, News & Similar companies | ZoomInfo.com
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in …See details»
Diversity, Inclusion & Belonging - Alkermes
The DIB Steering Committee is an employee-led group that provides perspectives and insights on DIB efforts at Alkermes. The committee works to: Shape the organization’s vision around …See details»
How This $4.3 Billion Pharma Company Is Helping Underserved
Aug 7, 2024 Richard Pops, CEO of Alkermes for over 30 years, transformed the company from 25 employees to a $4.3 billion valuation, focusing on neuroscience and stigmatized conditions.See details»
Alkermes 2019 Corporate Responsibility Report
ALKERMES • CORPORATE RESPONSIBILITY REPORT 2 A Message from Our CEO Alkermes was founded by pioneers in the field of neuroscience, and their legacy of innovation and …See details»
Alkermes plc (NASDAQ:ALKS) Shares Acquired by Xponance Inc.
21 hours ago NASDAQ ALKS opened at $33.88 on Wednesday. Alkermes plc has a 52 week low of $22.90 and a 52 week high of $36.45. The firm has a 50 day moving average of $33.21 …See details»
News - Alkermes
Feb 26, 2025 Alkermes applies its deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. …See details»
Is Alkermes plc (ALKS) the Best Healthcare Stock For Long-Term …
Mar 14, 2025 We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a look at where Alkermes plc (NASDAQ:ALKS) …See details»
Alkermes 2020 Corporate Responsibility Report
Alkermes is contributing to the creation of a healthcare system in which cutting-edge science, innovative medical practice and patient-focused advocacy come together to address some of …See details»
Will Alkermes' Proprietary Drugs Aid Growth Amid Stiff Competition?
2 days ago Alkermes plc (ALKS Quick Quote ALKS - Free Report) has made steady progress with its portfolio of proprietary products — Vivitrol (alcohol and opioid dependence), Aristada …See details»